|
|
Effect of Metformin and Ethynylestradiol Cyproteronee in the treatment of polycystic ovary syndrome infertility |
XIAO Jing HUANG Jia GUO Chen JIANG Ru▲ |
Department of Reproductive Health,Jiangxi Maternal and Child Health Hospital,Jiangxi Province,Nanchang 330006,China |
|
|
Abstract Objective To investigate the effect of Metformin and Ethynylestradiol Cyproterone in the treatment of polycystic ovary syndrome infertility.Methods A total of 60 cases of infertility patients with polycystic ovary syndrome from March 2015 to February 2016 treated in our hospital were selected as study subjects.They were divided into the control group and the study group according to the parity method,with 30 cases in each group.The control group was treated with Ethynylestradiol Cyproterone alone,and the study group was given Metformin on the basis of Ethynylestradiol Cyproterone.All patients were treated for 3 months.Sex hormone levels (follicle stimulating hormone[FSH],luteinizing hormone[LH],pituitary prolactin[PRL],testosterone[T],estradiol[E2],progesterone[P]),metabolic levels(Insulin receptor[IR],fasting insulin[FINS],fasting glucose[FBS]),postoperative ovulation status and adverse reactions were compared in two groups.Results The levels of LH([8.31±2.15]IU/L),T([1.32±0.38]nmol/L),E2([114.66±8.80]pmol/L),IR(1.66±0.54)and FINS([7.44±2.31]mIU/ml)in the study group were lower than those in the control group([11.34±2.39]IU/L,[1.94±0.48]nmol/L,[118.57±7.90]pmol/L,[2.60±0.57],[12.00±2.69]mIU/ml),and abortion rate(3.33%)in the study group were lower than that in the control group (20.00%),the ovulation rate (73.33%)and pregnancy rate(43.33%)in the study group were higher than those in the control group(53.33%,23.33%),and the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between two groups(P>0.05).ConclusionThe effect of Metformin and Ethynylestradiol Cyproterone in the treatment of infertility patients with polycystic ovary syndrome is significant.
|
|
|
|
|
[1] |
赵松青,方成霞.炔雌醇环丙孕酮联合二甲双胍对多囊卵巢综合征患者内分泌及糖脂代谢的影响[J].徐州医学院学报,2016,36(9):578-581.
|
[2] |
张新花,寇立巧,张静,等.温肾促排汤联合炔雌醇环丙孕酮、二甲双胍对多囊卵巢综合征患者糖脂代谢的影响[J].医疗装备,2016,29(3):157-159.
|
[3] |
陈红霞.炔雌醇环丙孕酮联合二甲双胍治疗青春期多囊卵巢综合征的临床效果观察[J].现代实用医学,2017,29(1):80-81.
|
[4] |
张乌云.炔雌醇环丙孕酮分别联合二甲双胍、吡格列酮治疗多囊卵巢综合征的疗效和安全性比较[J].实用妇科内分泌杂志(电子版),2017,4(21):31.
|
[5] |
王靖雯,蒋凤艳.炔雌醇环丙孕酮与屈螺酮炔雌醇对多囊卵巢综合征高雄激素血症的治疗作用[J].山东医药,2016,56(5):75-76.
|
[6] |
陈红九,张雯婷,范明.炔雌醇环丙孕酮合用二甲双胍治疗多囊卵巢综合征65例临床观察[J].福建医药杂志,2015,37(3):90-93.
|
[7] |
李晓燕,张蓓,林莉.炔雌醇环丙孕酮分别联合二甲双胍、吡格列酮治疗多囊卵巢综合征的疗效和安全性比较[J].中国药房,2016,27(36):5073-5075.
|
[8] |
魏颖.复方醋酸环丙孕酮与二甲双胍干预对改善多囊卵巢综合征内分泌的影响分析[J].实用妇科内分泌杂志(电子版),2016,3(7):20.
|
[9] |
郭三英,林柏珠,曾华华.二甲双胍联合炔雌醇环丙孕酮片治疗多囊卵巢综合征的临床效果[J].福建医药杂志,2017,39(1):105-107.
|
[10] |
朱中慧.二甲双胍联合炔雌醇环丙孕酮片治疗多囊卵巢综合征并不孕症的临床效果分析[J].实用妇科内分泌杂志(电子版),2016,3(13):152-153.
|
[11] |
赵艳丽.骨化三醇联合二甲双胍治疗多囊卵巢综合征的疗效及对血清单核细胞趋化因子-1的影响[J].中国基层医药,2017,24(5):747-750.
|
[12] |
连熙娜.二甲双胍与达英-35联合治疗多囊卵巢综合征的临床疗效研究[J].海峡药学,2016,28(10):161.
|
[13] |
韩西娟.达英-35联合二甲双胍对青春期多囊卵巢综合征卵巢功能的影响[J].中国妇幼保健,2016,31(3):569-571.
|
[14] |
陈祥艳.妈富隆联合二甲双胍治疗多囊卵巢综合征疗效研究[J].中国医学工程,2015,23(9):75.
|
[15] |
高梅.分析多囊卵巢综合征采用二甲双胍联合炔雌醇环丙孕酮片治疗的疗效[J].世界中医药,2017,12(A1):399.
|
[16] |
徐婉妍,徐小凤,麦今宝,等.二甲双胍在多囊卵巢综合征促排卵治疗中的作用分析[J].中国医药科学,2016,6(17):87-89.
|
[17] |
刘玉婷,刘东方,杨刚毅,等.二甲双胍治疗多囊卵巢综合征的临床效果[J].中国当代医药,2017,24(32):46-49.
|
[18] |
于淼淼,张艳梅,党洁明,等.雌激素与二甲双胍联合治疗青春期多囊卵巢综合征的临床疗效分析[J].中国性科学,2017,26(4):38-41.
|
[19] |
田瑜.二甲双胍联合炔雌醇环丙孕酮对多囊卵巢综合征不孕症患者促排卵后妊娠率的影响[J].中外医学研究,2017,15(17):146-147.
|
[20] |
刘莉莉,任长安.二甲双胍联合中医综合疗法对肾虚血瘀型多囊卵巢综合征不孕患者促排卵疗效的临床观察[J].中国现代医生,2017,55(17):131-134.
|
[21] |
辛俊,郭慧梅,谭同焕,等.自拟中药排卵汤联合炔雌醇环丙孕酮片治疗多囊卵巢综合征的临床效果研究[J].临床和实验医学杂志,2017,16(3):293-295.
|
|
|
|